Triazolevernetzte macrocyclische Peptide

Patent europeic · EP2114428 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2114428
Numer da la dumonda
EP08730678
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-02-2008
Publitgà
11-11-2009
Concedì
31-10-2012
Stritgà
29-02-2020
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 38/00 (2006.01)
Prioritad
US 903073 P 23.02.2007
Dumonda PCT
PCT/US2008/054922 25.02.2008
Publicaziun PCT
WO2008/104000 28.08.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.09.2020

  2. 16-01-2013

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 16.01.2013

  3. 28-12-2012

    Adressa midada

    Owner
    Aileron Therapeutics, Inc., 840 Memorial Drive, Cambridge, MA 02139, USA → Aileron Therapeutics, Inc., 281 Albany Street, Cambridge, MA 02139, USA

    Published in Swissreg on 28.12.2012

  4. 31-10-2012

    Concedì

    Published in Swissreg on 31.10.2012

Partidas

Possessur

Aileron Therapeutics, Inc.

281 Albany Street, Cambridge, MA 02139, US

Represchentant

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventur

NASH, Huw, M.

Concord, MA 01742, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.